NDTV-Dettol Banega Swasth Swachh India NDTV-Dettol Banega Swasth Swachh India

Coronavirus Explainers

Study Finds SARS-CoV-2 Responses Varied Significantly Depending On Cell Types

The study, co-led by Murdoch Children’s Research Institute and the Peter Doherty Institute for Infection and Immunity (Doherty Institute), discovered that SARS-CoV-2 responses varied significantly depending on cell type, allowing the researchers to identify effective anti-viral drugs to treat infection in heart and lung cells

Study Finds SARS-CoV-2 Responses Varied Significantly Depending On Cell Types
The findings were reported in Stem Cell Reports' 10th anniversary issue

Parkville: Researchers employed heart and lung stem cells infected with the virus that causes COVID-19 to better understand how the illness affects various organs, paving the path for more tailored therapies. The study, co-led by Murdoch Children’s Research Institute and the Peter Doherty Institute for Infection and Immunity (Doherty Institute), discovered that SARS-CoV-2 responses varied significantly depending on cell type, allowing the researchers to identify effective anti-viral drugs to treat infection in heart and lung cells. The findings were reported in Stem Cell Reports’ 10th anniversary issue.

Also Read: Study Discovers Long Covid-19 Patients Suffer From Persistent Inflammation

Murdoch Children’s Associate Professor David Elliott, also a principal investigator at The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), said discovering that COVID-19 triggered variable cellular responses in different organs would provide new insights into treatment strategies.

To further our knowledge on the impact of SARS-CoV-2 on different organs, we engineered human stem cells in the lab into lung and heart cells and infected with them with the virus. We found the heart and lungs exhibit distinct antiviral and toxicity profiles that could inform better COVID-19 therapies and treat its complications. Our findings highlight the importance of using several cell types for the evaluation of antiviral drugs to determine the best drug combinations for effective treatment of a virus that affects multiple organ systems, he said.

The Royal Melbourne Hospital and University of Melbourne Professor Kanta Subbarao, Virologist and Director of the WHO Collaborating Centre for Reference and Research on Influenza at the Doherty Institute, said while SARS-CoV-2 primarily infected the respiratory tract, lung and cardiac complications occur in severe cases of Covid-19.

Cardiac complications are observed in up to 78 per cent of recovered Covid-19 patients and ongoing myocardial inflammation in 60 per cent of patients.

Although COVID-19 vaccines are highly effective in preventing severe illness and death, antiviral compounds are required for the treatment of Covid-19, particularly with the emergence of variant viruses that evade immunity. To date, only a handful of drugs have been approved for use in hospitalised Covid-19 patients and more are needed,” Professor Subbarao said.

The study also looked at approved drugs for treating Covid-19, including Remdesivir and Molnupiravir, with some found to be more effective than others at treating infection in lung and heart stem cells. It identified Alectinib and SPHINX31 as promising antivirals for SARS-CoV-2 in both heart and lung cells.

We have provided valuable insights into virus-host interactions in tissues that are significantly affected in Covid-19, with implications that will further therapeutic options, Professor Subbarao said.

Also Read: Long Covid Can Impact Quality Of Life More Than Some Cancers: Study

(This story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol have been working towards a clean and healthy India since 2014 via the Banega Swachh India initiative, which is helmed by Campaign Ambassador Amitabh Bachchan. The campaign aims to highlight the inter-dependency of humans and the environment, and of humans on one another with the focus on One Health, One Planet, One Future – Leaving No One Behind. It stresses on the need to take care of, and consider, everyone’s health in India – especially vulnerable communities – theLGBTQ population,indigenous people, India’s different tribes, ethnic and linguistic minorities, people with disabilities, migrants, geographically remote populations, gender and sexual minorities. In wake of the currentCOVID-19 pandemic, the need for WASH (Water,SanitationandHygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign will continue to raise awareness on the same along with focussing on the importance of nutrition and healthcare for women and children, fightmalnutrition, mental wellbeing, self care, science and health,adolescent health & gender awareness. Along with the health of people, the campaign has realised the need to also take care of the health of the eco-system. Our environment is fragile due to human activity, which is not only over-exploiting available resources, but also generating immense pollution as a result of using and extracting those resources. The imbalance has also led to immense biodiversity loss that has caused one of the biggest threats to human survival – climate change. It has now been described as a “code red for humanity.” The campaign will continue to cover issues likeair pollution,waste management,plastic ban,manual scavengingand sanitation workers andmenstrual hygiene. Banega Swasth India will also be taking forward the dream of Swasth Bharat, the campaign feels that only a Swachh or clean India wheretoiletsare used andopen defecation free (ODF)status achieved as part of the Swachh Bharat Abhiyan launched byPrime Minister Narendra Modiin 2014, can eradicate diseases like diahorrea and the country can become a Swasth or healthy India.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This website follows the DNPA Code of Ethics

© Copyright NDTV Convergence Limited 2024. All rights reserved.